Psyadon Pharmaceuticals' Series A Round

Psyadon Pharmaceuticals raised a round of funding on July 14, 2004.

Psaydon Pharmaceuticals, formerly Ruxton Pharmaceuticals, is dedicated to the discovery and development of new treatments for serious neurological and psychiatric diseases. Ecopipam was the company's …

Articles about Psyadon Pharmaceuticals' Series A Round: